Skip to main content
Top
Published in: Supportive Care in Cancer 1/2017

01-01-2017 | Original Article

Nutritional issues and body weight in long-term survivors of allogeneic blood and marrow transplant (BMT) in NSW Australia

Authors: Jennifer Smith, Christine Poon, Nicole Gilroy, Masura Kabir, Lisa Brice, Gemma Dyer, Megan Hogg, Matthew Greenwood, John Moore, Mark Hertzberg, Louisa Brown, Jeff Tan, Gillian Huang, John Kwan, Stephen Larsen, Christopher Ward, Ian Kerridge

Published in: Supportive Care in Cancer | Issue 1/2017

Login to get access

Abstract

Purpose

The aims of this study were to describe the long-term nutrition, body weight and body image issues facing survivors of Allogeneic Blood and Marrow Transplant (BMT) and their impact on quality of life. It also describes survivors’ perception of enteral feeding during BMT.

Methods

Four hundred and forty-one survivors who had undergone a BMT in NSW, Australia between 2000 and 2012 (n = 441/583) completed the Sydney Post BMT Study Survey (SPBS).

Results

Forty-five percent of survivors less than 2-year post-transplant reported a dry mouth, 36 % reported mouth ulcers and 19 % had diarrhoea. This was consistent across all survivor groups, regardless of time since transplant. Patients with one or more gastrointestinal (GI) symptoms had significantly lower quality of life scores. There was a significant difference in quality of life scores when comparing those with no GI symptoms to those with one or more symptoms (P = <0.0001). Quality of life was significantly higher in those who once again enjoyed mealtimes (P < 0.0001). Males were more likely to be satisfied with their body weight compared to females (P = 0.009). The median body mass index (BMI) for all patients reporting body weight satisfaction was significantly lower (BMI 23.5) than those reporting dissatisfaction (BMI 27.5) (P = <0.0001). Survivors who had a normal BMI had significantly higher rates of body weight satisfaction compared to underweight, overweight and obese survivors (P = <0.0001). Those survivors who were overweight or obese were significantly more likely to be diabetic (P = 0.008).

Conclusion

This study revealed an important relationship between gastrointestinal symptoms, body weight and body image and survivor’s quality of life. It provides further support for the importance of nutrition therapy post-BMT.
Literature
1.
go back to reference Gifford G, Sim J, Horne A, Ma D (2014) Health status, late effects and long-term survivorship of allogeneic bone marrow transplantation: a retrospective study. Intern Med J 44(2):139–147CrossRefPubMed Gifford G, Sim J, Horne A, Ma D (2014) Health status, late effects and long-term survivorship of allogeneic bone marrow transplantation: a retrospective study. Intern Med J 44(2):139–147CrossRefPubMed
2.
go back to reference Savani BN, Griffith ML, Jagasia S, Lee SJ (2011) How I treat late effects in adults after allogeneic stem cell transplantation. Blood 117(11):3002–3009CrossRefPubMedPubMedCentral Savani BN, Griffith ML, Jagasia S, Lee SJ (2011) How I treat late effects in adults after allogeneic stem cell transplantation. Blood 117(11):3002–3009CrossRefPubMedPubMedCentral
3.
go back to reference Nivison-Smith I, Bardy P, Dodds AJ, Ma DD, Aarons D, Tran S, et al. (2016) A review of hematopoietic cell transplantation in Australia and New Zealand, 2005 to 2013. Biol Blood Marrow Transplant. 22(2):284–291CrossRefPubMed Nivison-Smith I, Bardy P, Dodds AJ, Ma DD, Aarons D, Tran S, et al. (2016) A review of hematopoietic cell transplantation in Australia and New Zealand, 2005 to 2013. Biol Blood Marrow Transplant. 22(2):284–291CrossRefPubMed
4.
go back to reference Majhail NS, Farnia SH, Carpenter PA, Champlin RE, Crawford S, Marks DI, et al. (2015) Indications for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 21(11):1863–1869CrossRefPubMedPubMedCentral Majhail NS, Farnia SH, Carpenter PA, Champlin RE, Crawford S, Marks DI, et al. (2015) Indications for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 21(11):1863–1869CrossRefPubMedPubMedCentral
5.
go back to reference Armenian SH, Sun CL, Vase T, Ness KK, Blum E, Francisco L, et al. (2012) Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease. Blood 120(23):4505–4512CrossRefPubMedPubMedCentral Armenian SH, Sun CL, Vase T, Ness KK, Blum E, Francisco L, et al. (2012) Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease. Blood 120(23):4505–4512CrossRefPubMedPubMedCentral
6.
go back to reference Majhail NS, Flowers ME, Ness KK, Jagasia M, Carpenter PA, Arora M, et al. (2009) High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 43(1):49–54CrossRefPubMed Majhail NS, Flowers ME, Ness KK, Jagasia M, Carpenter PA, Arora M, et al. (2009) High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 43(1):49–54CrossRefPubMed
7.
go back to reference Rizzo JD, Wingard JR, Tichelli A, Lee SJ, Van Lint MT, Burns LJ, et al. (2006) Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT. Bone Marrow Transplant 37(3):249–261CrossRefPubMed Rizzo JD, Wingard JR, Tichelli A, Lee SJ, Van Lint MT, Burns LJ, et al. (2006) Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT. Bone Marrow Transplant 37(3):249–261CrossRefPubMed
8.
go back to reference Lipkin AC, Lenssen P, Dickson BJ (2005) Nutrition issues in hematopoietic stem cell transplantation: state of the art. Nutr Clin Pract 20(4):423–439CrossRefPubMed Lipkin AC, Lenssen P, Dickson BJ (2005) Nutrition issues in hematopoietic stem cell transplantation: state of the art. Nutr Clin Pract 20(4):423–439CrossRefPubMed
9.
go back to reference Mattsson J, Westin S, Edlund S, Remberger M (2006) Poor oral nutrition after allogeneic stem cell transplantation correlates significantly with severe graft-versus-host disease. Bone Marrow Transplant 38(9):629–633CrossRefPubMed Mattsson J, Westin S, Edlund S, Remberger M (2006) Poor oral nutrition after allogeneic stem cell transplantation correlates significantly with severe graft-versus-host disease. Bone Marrow Transplant 38(9):629–633CrossRefPubMed
10.
go back to reference Martin-Salces M, de Paz R, Canales MA, Mesejo A, Hernandez-Navarro F (2008) Nutritional recommendations in hematopoietic stem cell transplantation. Nutrition 24(7–8):769–775CrossRefPubMed Martin-Salces M, de Paz R, Canales MA, Mesejo A, Hernandez-Navarro F (2008) Nutritional recommendations in hematopoietic stem cell transplantation. Nutrition 24(7–8):769–775CrossRefPubMed
11.
go back to reference Horsley P, Bauer J, Gallagher B (2005) Poor nutritional status prior to peripheral blood stem cell transplantation is associated with increased length of hospital stay. Bone Marrow Transplant 35(11):1113–1116CrossRefPubMed Horsley P, Bauer J, Gallagher B (2005) Poor nutritional status prior to peripheral blood stem cell transplantation is associated with increased length of hospital stay. Bone Marrow Transplant 35(11):1113–1116CrossRefPubMed
12.
go back to reference Thompson JL, Duffy J (2008) Nutrition support challenges in hematopoietic stem cell transplant patients. Nutr Clin Pract 23(5):533–546CrossRefPubMed Thompson JL, Duffy J (2008) Nutrition support challenges in hematopoietic stem cell transplant patients. Nutr Clin Pract 23(5):533–546CrossRefPubMed
13.
go back to reference Bozzetti F, Arends J, Lundholm K, Micklewright A, Zurcher G, Muscaritoli M, et al. (2009) ESPEN guidelines on parenteral nutrition: non-surgical oncology. Clin Nutr 28(4):445–454CrossRefPubMed Bozzetti F, Arends J, Lundholm K, Micklewright A, Zurcher G, Muscaritoli M, et al. (2009) ESPEN guidelines on parenteral nutrition: non-surgical oncology. Clin Nutr 28(4):445–454CrossRefPubMed
14.
go back to reference Tichelli A, Passweg J, Wojcik D, Rovo A, Harousseau JL, Masszi T, et al. (2008) Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Haematologica 93(8):1203–1210CrossRefPubMed Tichelli A, Passweg J, Wojcik D, Rovo A, Harousseau JL, Masszi T, et al. (2008) Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Haematologica 93(8):1203–1210CrossRefPubMed
15.
go back to reference Urbain PBJ, Lambert C, Finke J, Bertz H, Biesalski HK (2013) Longitudinal follow up of nutritional status amd its influencing factor in adults undergoing allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 48:446–451CrossRefPubMed Urbain PBJ, Lambert C, Finke J, Bertz H, Biesalski HK (2013) Longitudinal follow up of nutritional status amd its influencing factor in adults undergoing allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 48:446–451CrossRefPubMed
16.
go back to reference McQuellon RP, Russell GB, Cella DF, Craven BL, Brady M, Bonomi A, et al. (1997) Quality of life measurement in bone marrow transplantation: development of the functional assessment of cancer therapy-bone marrow transplant (FACT-BMT) scale. Bone Marrow Transplant 19(4):357–368CrossRefPubMed McQuellon RP, Russell GB, Cella DF, Craven BL, Brady M, Bonomi A, et al. (1997) Quality of life measurement in bone marrow transplantation: development of the functional assessment of cancer therapy-bone marrow transplant (FACT-BMT) scale. Bone Marrow Transplant 19(4):357–368CrossRefPubMed
17.
go back to reference Pavletic SZ, Martin P, Lee SJ, Mitchell S, Jacobsohn D, Cowen EW, et al. (2006) Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. Response criteria working group report. Biol Blood Marrow Transplant. 12(3):252–266CrossRefPubMed Pavletic SZ, Martin P, Lee SJ, Mitchell S, Jacobsohn D, Cowen EW, et al. (2006) Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. Response criteria working group report. Biol Blood Marrow Transplant. 12(3):252–266CrossRefPubMed
18.
go back to reference Lee S, Cook EF, Soiffer R, Antin JH (2002) Development and validation of a scale to measure symptoms of chronic graft-versus-host disease. Biol Blood Marrow Transplant 8(8):444–452CrossRefPubMed Lee S, Cook EF, Soiffer R, Antin JH (2002) Development and validation of a scale to measure symptoms of chronic graft-versus-host disease. Biol Blood Marrow Transplant 8(8):444–452CrossRefPubMed
19.
go back to reference Lovibond SH LP. Manual for the depression anxiety stress scales: Psychology Foundation of Australia; 1996. Lovibond SH LP. Manual for the depression anxiety stress scales: Psychology Foundation of Australia; 1996.
20.
go back to reference Tedeschi RG, Calhoun LG (1996) The posttraumatic growth inventory: measuring the positive legacy of trauma. J Trauma Stress 9(3):455–471CrossRefPubMed Tedeschi RG, Calhoun LG (1996) The posttraumatic growth inventory: measuring the positive legacy of trauma. J Trauma Stress 9(3):455–471CrossRefPubMed
21.
go back to reference Greenberg DB, Kornblith AB, Herndon JE, Zuckerman E, Schiffer CA, Weiss RB, et al. (1997) Quality of life for adult leukemia survivors treated on clinical trials of cancer and leukemia group B during the period 1971-1988: predictors for later psychologic distress. Cancer 80(10):1936–1944CrossRefPubMed Greenberg DB, Kornblith AB, Herndon JE, Zuckerman E, Schiffer CA, Weiss RB, et al. (1997) Quality of life for adult leukemia survivors treated on clinical trials of cancer and leukemia group B during the period 1971-1988: predictors for later psychologic distress. Cancer 80(10):1936–1944CrossRefPubMed
22.
go back to reference Kornblith AB, Huang HQ, Walker JL, Spirtos NM, Rotmensch J, Cella D (2009) Quality of life of patients with endometrial cancer undergoing laparoscopic international federation of gynecology and obstetrics staging compared with laparotomy: a gynecologic oncology group study.[erratum appears in J Clin Oncol. 2010 Jun 1;28(16):2805]. J Clin Oncol 27(32):5337–5342CrossRefPubMedPubMedCentral Kornblith AB, Huang HQ, Walker JL, Spirtos NM, Rotmensch J, Cella D (2009) Quality of life of patients with endometrial cancer undergoing laparoscopic international federation of gynecology and obstetrics staging compared with laparotomy: a gynecologic oncology group study.[erratum appears in J Clin Oncol. 2010 Jun 1;28(16):2805]. J Clin Oncol 27(32):5337–5342CrossRefPubMedPubMedCentral
23.
go back to reference Webster K, Cella D, Yost K (2003) The functional assessment of chronic illness therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual Life Outcomes 1:79CrossRefPubMedPubMedCentral Webster K, Cella D, Yost K (2003) The functional assessment of chronic illness therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual Life Outcomes 1:79CrossRefPubMedPubMedCentral
24.
go back to reference WHO. Body Mass Index – BMI WHO Regional Office for Europe UN City Marmorvej 51 DK-2100 Copenhagen Denmark: World Health Organization; 2015. Available from: http://www.euro.who.int/en/health-topics/disease-prevention/nutrition/a-healthy-lifestyle/body-mass-index-bmi. WHO. Body Mass Index – BMI WHO Regional Office for Europe UN City Marmorvej 51 DK-2100 Copenhagen Denmark: World Health Organization; 2015. Available from: http://​www.​euro.​who.​int/​en/​health-topics/​disease-prevention/​nutrition/​a-healthy-lifestyle/​body-mass-index-bmi.​
25.
go back to reference Lenssen PS (1990) ME; Cheney, CL; Nims, JW; Sullivan, KM; stern, JM; Moe, G; Aker, SN. Prevalence of nutrition-related problems among long-term survivors of allogeneic marrow transplantation. J Am Diet Assoc 90(6):835–842PubMed Lenssen PS (1990) ME; Cheney, CL; Nims, JW; Sullivan, KM; stern, JM; Moe, G; Aker, SN. Prevalence of nutrition-related problems among long-term survivors of allogeneic marrow transplantation. J Am Diet Assoc 90(6):835–842PubMed
26.
go back to reference Government A. Australian Bureau of Statistics Australian Health Survey 2011–2012. Available from: http://www.aihw.gov.au/overweight-and-obesity/. Government A. Australian Bureau of Statistics Australian Health Survey 2011–2012. Available from: http://​www.​aihw.​gov.​au/​overweight-and-obesity/​.​
27.
go back to reference Raynard B, Nitenberg G, Gory-Delabaere G, Bourhis JH, Bachmann P, Bensadoun RJ, et al. (2003) Summary of the standards, options and recommendations for nutritional support in patients undergoing bone marrow transplantation (2002. Br J Cancer 89(Suppl 1):S101–S106CrossRefPubMedPubMedCentral Raynard B, Nitenberg G, Gory-Delabaere G, Bourhis JH, Bachmann P, Bensadoun RJ, et al. (2003) Summary of the standards, options and recommendations for nutritional support in patients undergoing bone marrow transplantation (2002. Br J Cancer 89(Suppl 1):S101–S106CrossRefPubMedPubMedCentral
Metadata
Title
Nutritional issues and body weight in long-term survivors of allogeneic blood and marrow transplant (BMT) in NSW Australia
Authors
Jennifer Smith
Christine Poon
Nicole Gilroy
Masura Kabir
Lisa Brice
Gemma Dyer
Megan Hogg
Matthew Greenwood
John Moore
Mark Hertzberg
Louisa Brown
Jeff Tan
Gillian Huang
John Kwan
Stephen Larsen
Christopher Ward
Ian Kerridge
Publication date
01-01-2017
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 1/2017
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-016-3398-5

Other articles of this Issue 1/2017

Supportive Care in Cancer 1/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine